Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells

Protein and Peptide Letters

Volumn 17, Issue 8, 2010, Pages 1031-1039

  EL Fakharany, Esmail M ^a   Haroun, Bakry M ^b   Ng, Tzi Bun ^c   Redwan, EL Rashdy M ^a  

^a Universities and Research centers District   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Hepatitis C virus; Intracellular blocking; Laccase; Mushroom; Neutralization; Purification

Indexed keywords

BASIDIOMYCOTA; HEPATITIS C VIRUS; PLEUROTUS OSTREATUS;

LACCASE;

CELL CULTURE; CELL SURVIVAL; CYTOLOGY; ENZYMOLOGY; HEPACIVIRUS; HUMAN; ISOLATION AND PURIFICATION; LEUKOCYTE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PH; PHYSIOLOGY; PLEUROTUS; TEMPERATURE; TUMOR CELL LINE; VIROLOGY; VIRUS ENTRY;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; HEPACIVIRUS; HUMANS; HYDROGEN-ION CONCENTRATION; LACCASE; LEUKOCYTES; LIVER NEOPLASMS; PLEUROTUS; TEMPERATURE; VIRUS INTERNALIZATION;

EID: 77958075970     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610791498948     Document Type: Article

References (53)

1. Schnell, J.R.; Chou, J.J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature, 2008, 451, 591-595.
2. Pielak, R.M.; Jason, R.; Schnell, J.R.; Chou, J.J. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc. Natl. Acad. Sci. USA, 2009, 106, 7379-7384.
3. Huang, R.B.; Du, Q.S.; Wang, C.H.; Chou, K.C. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus. Biochem. Biophys. Res. Comm., 2008, 377, 1243-1247.
4. Du, Q.S.; Huang, R.B.; Wang, C.H.; Li, X.M.; Chou, K.C. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J. Theor. Biol., 2009, 259, 159-164.
5. Wei, H.; Wang, C.H.; Du, Q.S.; Meng, J.; Chou, K.C. Investigation into adamantane-based M2 inhibitors with FB-QSAR. Med. Chem., 2009, 5, 305-317.
6. Wang, J.F.; Wei, D.Q.; Chou, K.C. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus. Biochem. Biophys. Res. Commun., 2009, 388, 413-417.
7. Wang, S.Q.; Du, Q.S.; Huang, R.B.; Zhang, D.W.; Chou, K.C. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Biochem. Biophys. Res. Commun., 2009, 386, 432-436.
8. Wei, D.Q.; Du, Q.S.; Sun, H.; Chou, K.C. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. Biochem. Biophys. Res. Comm., 2006, 344, 1048-1055.
9. Wang, S.Q.; Du, Q.S.; Chou, K.C. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases. Biochem. Biophys. Res. Comm., 2007, 354, 634-640.
10. Gong, K.; Li, L.; Wang, J.F.; Cheng, F.; Wei, D.Q.; Chou, K.C. Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design. Med. Chem., 2009, 5, 242-249.
11. Xiao, X.; Shao, S.H.; Chou, K.C. A probability cellular automaton model for hepatitis B viral infections. Biochem. Biophys. Res. Comm., 2006, 342, 605-610.
12. Yokoyama, Y.; Kuramitsu, Y.; Takashima, M. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics., 2004, 4, 2111-2116.
13. Simmonds, P.; Smith, D.B.; McOmish, F. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J. Gen. Virol., 1994, 75 (Pt 5), 1053-1061.
14. O'Brien, T.R.; Kirk, G.; Zhang, M. Hepatocellular carcinoma paradigm of preventive oncology. Cancer J., 2004, 10, 67-73.
15. Tanaka, J.; Yoshizawa, H. A national project for the management of viral hepatitis toward prevention of hepatocellular carcinoma in Japan. Gan To Kagaku Ryoho., 2004, 31, 864-870.
16. Nousbam, J. Genomic subtypes of hepatitis C virus: epidemiology, diagnosis and clinical consequences. Bull. Soc. Pathol. Exot., 1998, 91(1), 29-33.
17. NIH Consensus NIH Statement on management of Hepatitis C: 2002 NIH Consens state Sci. Statement, 2002, 19(3), 1-46.
18. EL-Zayada, A.; Selim, O.; Haddad, S. Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients. Ital. J. Gastrroenterol. Hepato., 1999, 31(6), 472-5.
19. World Health Organization: WHO Tradional Medicine Strategy 2002-2005. In: 2002-2005: Available at: http://www.who.int/medicines/library/trm/trm_strat_eng.pdf. Accessed on June 18/04.
20. Wang, H.X.; Ng, T.B. Isolation of a novel ubiquitin-like protein from Pleurotus ostreatus mushroom with anti-human immunodeficiency virus, translation-inhibitory, and ribonuclease activities. Biochem. Biophys. Res. Commun., 2000, 276, 587-93.
21. Wang, H.X.; Ng, T.B. A new ribonuclease from the black oyster mushroom Pleurotus ostreatus. Peptides, 2004, 25, 685-7.
22. Ng, T.B.; Wang, H.X. A homodimeric laccase with unqiue characteristics from the yellow mushroom Cantharellus cibarius. Biochem. Biophys. Res. Commun., 2004, 313, 37-41.
23. Wang, J.; Wang, H.X.; Ng, T.B. A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa. Peptides. 2007, 28, 560-565.
24. Sagakami, H.; Aohi, T.; Simpson, A.; Tanuma, S. Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK. J. Anticancer Res., 1991, 11, 993-1000.
25. Wasser, S.P.; Weis, A.L. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit. Rev. Immunol., 1999, 19, 65-96.
26. Gunde-Cimerman, N. Medicinal value of the genus Pleurotus (Fr.) P. Karst. (Agaricales s.l. Basidiomycetes). Int. J. Med. Mushroom., 1999, 1, 69-80.
27. Kües, U.; Liu, Y. Fruiting body production in Basidiomycetes. Appl. Microbiol. Biotechnol., 2000, 54, 141-152.
28. Evans, C.S.; Dutton, M.V.; Guillen, F.; Veness, R.G. Enzymes and small molecular mass agents involved with lignocellulose degradation. FEMS Microbiol Rev., 1994, 13, 235-240.
29. Martirani, L.; Giardina, P.; Marzullo, L.; Sannia, G. Reduction of phenol content and toxicity in olive oil mill waste waters with the ligninolytic fungus Pleurotus ostreatus. Water Res., 1996, 30, 1914-1918.
30. El-FFakharany, E. M.; Tabll, A.; Abd El-WWahab, A.; Haroun M.B.; Redwan, E. M. Potential activity of camel milk-amylase and lactoferrin against hepatitis C virus infectivity in HepG2 and Lymphocytes. J. Hep. Monthly., 2008, 8(2), 57-64.
31. Gianna Palmieri, G.; Giardina, P.; Bianco, C.; Scaloni, A.; Capassoi, A.; Sannia, G. A Novel white laccase from Pleurotus ostreatus. J. Biol. Chem., 1997, 272, 31301-307.
32. Okamoto, K.; Yanagi, S.O.; Skai, T. Purification and characterization of extracellular laccase from Pleurotus ostreatus. Micoscience. 2000, 41, 7-13.
33. Bradford, M.M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem., 1976, 72, 248-254.
34. Shin, K.S.; Lee, Y.J. Purification and characterization of a new member of the laccase family from the white-rot basidiomycete Coriolus hirsutus. J. Arch. Biochem. Biophys., 2000, 384, 109-115.
35. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227, 680-685.
36. Sambrook, J.; Russell, D.W. Molecular cloning: A laboratory manual, 3rd Ed. Cold Spring Harbor, New York, U.S.A., Cold Spring Harbor Laboratory Press, 2001.
37. Redwan, El-R.M.; Tabll, A. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes. J. Immunoassay Immunochem., 2007, 28, 267-277.
38. El-Fakharany, E.M.; Tabll, A.; El-Wahab, A.A.; Haroun, B.M.; EL-Rashdy, M.; Redwan. Potential activity of camel milk-amylase and lactoferrin against hepatitis C virus infectivity in HepG2 and lymphocytes. Hepatitis Monthly., 2008, 8(2), 101-109.
39. Ikeda, M.; Nozaki, A.; Sugiyama, K. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun., 1998, 245, 549-553.
40. Ikeda, M.; Nozaki, A.; Sugiyama, K. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. J. Virus Res., 2000, 66, 51-63.
41. Fournier, C.; Duverlie, G.; Francois, C. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies. Virol., 2007, 4, 35.
42. Ngai, P.H.; Ng, T.B. Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemic cells. J. Life Sci., 2003, 73, 3363-74.
43. Wang, H.X.; Ng, T.B. Purification of a novel low molecular-mass laccase with HIV-1 reverse transcriptase inhibitory activity from the mushroom Tricholoma giganteum. Biochem. Biophys. Res. Commun., 2004, 315, 450-4.
44. Kobayashi, H.; Inokuchi, N.; Koyama, T.; Watenabe H.; Iwami, M.; Ohgi, K.; Irie, M. Primary structure of the nonspecific and adenylic acid preferential ribonuclease from the fruit bodies of Lentinus edodes. J. Biosci. Biotechnol. Biochem., 1992, 55, 2003-2010.
45. Lam, S.K.; Ng, T. B. First simultaneous isolation of a ribosome inactivating protein and an antifungal protein from a mushroom (Lyophyllum shimeiji) together with evidence for synergism of their antifungal effects. Arch. Biochem. Biophys., 2001, 39, 271-280.
46. Wang, H.X.; Ng, T.B. Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus transcriptase and glycohydrolase. J. Planta Med., 2001, 67, 669-672.
47. She, Q.B.; Ng, T.B.; Liu, W.K. A novel lectin with potent immunomodulatory activity isolated from both fruiting bodies and cultured mycelia of the edible mushroom Volvariella volvacea. Biochem. Biophys. Res. Commun., 1998, 247, 106-111.
48. Giardina, P.; Palmieri, G.; Scaloni, A. Protein and gene structure of a blue laccase from Pleurotus ostreatus. J. Biochem., 1999, 341, 655-663.
49. Garzillo, A.M.; Colao, M.C.; Buonocore, V. Structural and kinetic characterization of native laccases from Pleurotus ostreatus, Rigidoporus lignosus and Trametes trogii. J. Protein Chem., 2001, 20, 191-201.
50. Fukuda, T.; Uchida, H.; Takashima, Y. Degradation of bisphenol A by purified laccase from Trametes villosa. Biochem. Biophys. Res. Commun., 2001, 284, 704-706.
51. Tinoco, R.; Pickard, M.A.; Vazquez-Duhalt, R. Kinetic differences of purified laccases from six Pleurotus ostreatus strains. J. Lett. Appl. Microbiol., 2001, 32, 331-35.
52. Gregori, A.; Svagelj, M.; Pohleven, J. Cultivation techniques and medicinal properties of Pleurotus spp. J. Food Tech. Biotech., 2007, 45, 238-249.
53. Collins, R.A.; Ng, T.B.; Fong, W.P.; Wan, C.C.; Yeung, H.W. A comparison of human immunodeficiency virus type 1 inhibition by partially purified aqueous extracts of Chinese medicinal herbs. J. Life Sci., 1997, 60, 345-351.